Accès ouvert · CC BY

Hydroxyurea-Induced miRNA Expression in Sickle Cell Disease Patients in Africa

Article scientifique 2019 Sciences de la santé Anglais

Résumé

Hydroxyurea (HU) is clinically beneficial in Sickle Cell Disease (SCD) through foetal haemoglobin (HbF) induction; however, the mechanism of HU is not yet fully elucidated. Selected miRNAs have been associated with HU-induced HbF production. We have investigated differential HU-induced global miRNA expression in peripheral blood of adult SCD patients in patients from Congo, living in South Africa. We found 22 of 798 miRNAs evaluated that were differentially expressed under HU treatment, with the majority (13/22) being functionally associated with HbF-regulatory genes, including BCL11A (miR-148b-3p, miR-32-5p, miR-340-5p, miR-29c-3p), MYB (miR-105-5p), and KLF-3 (miR-106b-5), and SP1 (miR-29b-3p, miR-625-5p, miR-324-5p, miR-125a-5p, miR-99b-5p, miR-374b-5p, miR-145-5p). The study provides additional miRNA candidates for therapeutic exploration.

Citer ce document

Mnika, K., Mazandu, G. K., Jonas, M., Pule, G. D., Chimusa, E. R., Hanchard, N. A., & Wonkam, A. (2019). Hydroxyurea-Induced miRNA Expression in Sickle Cell Disease Patients in Africa. Frontiers in Genetics. https://doi.org/10.3389/fgene.2019.00509

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 02/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 18

Téléchargements (hors robots) : 0

Méthode de comptage